Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Lung cancer and related topics (MedlinePlus Genetics) were added and the Publications note now states that publications are automatically filled from PubMed, with the revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding notice at the bottom of the page has been removed. The study details and overall content remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T17:29:50.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - The related topics section no longer lists Lung cancer and MedlinePlus Genetics. This is a minor navigational/metadata change that does not affect the study content.
    Difference
    0.1%
    Check dated 2025-11-10T14:45:57.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    No significant changes were detected in core study details; observed updates seem limited to formatting or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T11:58:04.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added related topics Lung cancer and MedlinePlus Genetics to the study page. These additions provide quick access to disease context and genetics information.
    Difference
    0.1%
    Check dated 2025-10-27T08:41:23.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T17:20:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.